相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza
Andrew C. Hayward et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem
Adam K. Wheatley et al.
JOURNAL OF IMMUNOLOGY (2015)
High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response
Sarah F. Andrews et al.
JOURNAL OF VIROLOGY (2015)
Advancements in the development of subunit influenza vaccines
Naru Zhang et al.
MICROBES AND INFECTION (2015)
Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
Hongquan Wan et al.
NATURE COMMUNICATIONS (2015)
Influenza virus antigenicity and broadly neutralizing epitopes
Gillian M. Air
CURRENT OPINION IN VIROLOGY (2015)
Estimating the Life Course of Influenza A (H3N2) Antibody Responses from Cross-Sectional Data
Adam J. Kucharski et al.
PLOS BIOLOGY (2015)
Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza
Katherine A. Richards et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
Eleanor L. Ramos et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
Liudmila A. Stepanova et al.
PLOS ONE (2015)
Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates
Aihua Song et al.
ANTIVIRAL RESEARCH (2014)
Development of universal influenza vaccines based on influenza virus M and NP genes
M. Zheng et al.
INFECTION (2014)
Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine
Sinthujan Jegaskanda et al.
JOURNAL OF IMMUNOLOGY (2014)
Emergence in China of human disease due to avian influenza A(H10N8) - Cause for concern?
Kelvin K. W. To et al.
JOURNAL OF INFECTION (2014)
Identification of a Highly Conserved and Surface Exposed B-cell Epitope on the Nucleoprotein of Influenza A Virus
Xun Gui et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages
James R. R. Whittle et al.
JOURNAL OF VIROLOGY (2014)
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
Raffael Nachbagauer et al.
JOURNAL OF VIROLOGY (2014)
A Broadly Neutralizing Human Monoclonal Antibody Directed against a Novel Conserved Epitope on the Influenza Virus H3 Hemagglutinin Globular Head
Ebony Benjamin et al.
JOURNAL OF VIROLOGY (2014)
Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin
Gene S. Tan et al.
JOURNAL OF VIROLOGY (2014)
Universal influenza virus vaccines: need for clinical trials
Florian Krammer et al.
NATURE IMMUNOLOGY (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses
Shih-Chang Lin et al.
PLOS ONE (2014)
Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines
Yuan Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A common solution to group 2 influenza virus neutralization
Robert H. E. Friesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection
Vamsee V. A. Mallajosyula et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine
Jian Yan et al.
VACCINE (2014)
Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection
Min-Chul Kim et al.
ANTIVIRAL RESEARCH (2013)
An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
Gerald Nakamura et al.
CELL HOST & MICROBE (2013)
Outbreak of Variant Influenza A(H3N2) Virus in the United States
Michael A. Jhung et al.
CLINICAL INFECTIOUS DISEASES (2013)
Adjuvanted influenza vaccines
Orli Even-Or et al.
EXPERT REVIEW OF VACCINES (2013)
CD4+ T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine
Jennifer L. Nayak et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans
Matthew S. Miller et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine
Xiao-Song He et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Sequential Seasonal H1N1 Influenza Virus Infections Protect Ferrets against Novel 2009 H1N1 Influenza Virus
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2013)
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
Hongquan Wan et al.
JOURNAL OF VIROLOGY (2013)
H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
Irina Margine et al.
JOURNAL OF VIROLOGY (2013)
Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
Cyrille Dreyfus et al.
JOURNAL OF VIROLOGY (2013)
Standard Trivalent Influenza Virus Protein Vaccination Does Not Prime Antibody-Dependent Cellular Cytotoxicity in Macaques
Sinthujan Jegaskanda et al.
JOURNAL OF VIROLOGY (2013)
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
I. Margine et al.
JOURNAL OF VIROLOGY (2013)
Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques
Sinthujan Jegaskanda et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
The genesis and source of the H7N9 influenza viruses causing human infections in China
Tommy Tsan-Yuk Lam et al.
NATURE (2013)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
Boerries Brandenburg et al.
PLOS ONE (2013)
Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis
Matthew S. Miller et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination
Salah-Eddine Bentebibel et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination
Ning Jiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The emergence and diversification of panzootic H5N1 influenza viruses
Yi Guan et al.
VIRUS RESEARCH (2013)
Cross-protection against drifted influenza viruses Options offered by adjuvanted and intradermal vaccines
Andrea Orsi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
Lone Simonsen et al.
PLOS MEDICINE (2013)
New World Bats Harbor Diverse Influenza A Viruses
Suxiang Tong et al.
PLOS PATHOGENS (2013)
Recurring Influenza B Virus Infections in Seals
Rogier Bodewes et al.
EMERGING INFECTIOUS DISEASES (2013)
Germinal Centers
Gabriel D. Victora et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Antibody Breadth and Protective Efficacy Are Increased by Vaccination with Computationally Optimized Hemagglutinin but Not with Polyvalent Hemagglutinin-Based H5N1 Virus-Like Particle Vaccines
Brendan M. Giles et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells
Christopher Sundling et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection
Brendan M. Giles et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge
Gayathri Bommakanti et al.
JOURNAL OF VIROLOGY (2012)
Effect of Priming with H1N1 Influenza Viruses of Variable Antigenic Distances on Challenge with 2009 Pandemic H1N1 Virus
Christopher D. O'Donnell et al.
JOURNAL OF VIROLOGY (2012)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
Gene S. Tan et al.
JOURNAL OF VIROLOGY (2012)
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
Fatimah S. Dawood et al.
LANCET INFECTIOUS DISEASES (2012)
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C. Ekiert et al.
NATURE (2012)
Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles
Shih-Chang Lin et al.
PLOS ONE (2012)
A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
Richard D. Antrobus et al.
PLOS ONE (2012)
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
Gui-Mei Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
Natalie Pica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure
Chih-Jen Wei et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines
Robert B. Couch et al.
VACCINE (2012)
Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin
Xiaoyu Liu et al.
VACCINE (2012)
Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China
Justin Lessler et al.
PLOS PATHOGENS (2012)
Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem
C. A. Thomson et al.
FRONTIERS IN IMMUNOLOGY (2012)
Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
R. Bodewes et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
Jianhua Sui et al.
CLINICAL INFECTIOUS DISEASES (2011)
Influenza vaccine immunology
Philip R. Dormitzer et al.
IMMUNOLOGICAL REVIEWS (2011)
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
Karim El Bakkouri et al.
JOURNAL OF IMMUNOLOGY (2011)
The contribution of animal models to the understanding of the host range and virulence of influenza A viruses
Christopher D. O'Donnell et al.
MICROBES AND INFECTION (2011)
Immunity to seasonal and pandemic influenza A viruses
Sophie A. Valkenburg et al.
MICROBES AND INFECTION (2011)
Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin
Eric A. Weaver et al.
PLOS ONE (2011)
The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination
Heath Kelly et al.
PLOS ONE (2011)
H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination
M. Anthony Moody et al.
PLOS ONE (2011)
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
James R. R. Whittle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
Brendan M. Giles et al.
VACCINE (2011)
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Christine B. Turley et al.
VACCINE (2011)
Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates
Jason T. Weinfurter et al.
PLOS PATHOGENS (2011)
Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
Jeffery K. Taubenberger et al.
CELL HOST & MICROBE (2010)
Cross-protective immunity to influenza A viruses
Suzanne L. Epstein et al.
EXPERT REVIEW OF VACCINES (2010)
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
Davide Corti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus
Katherine A. Richards et al.
JOURNAL OF IMMUNOLOGY (2010)
Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment
John Steel et al.
JOURNAL OF VIROLOGY (2010)
Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell Responses to 2009 Pandemic H1N1 Swine-Origin Influenza A Virus
Xinhui Ge et al.
JOURNAL OF VIROLOGY (2010)
Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret
Srinivas S. Rao et al.
PLOS ONE (2010)
Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin
H. Keipp Talbot et al.
PLOS ONE (2010)
Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses
Andres G. Grandea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
Gayathri Bommakanti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Chih-Jen Wei et al.
SCIENCE (2010)
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
Filippo Ansaldi et al.
VACCINE (2010)
Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets
Ji-Young Min et al.
VIROLOGY (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
Taia T. Wang et al.
PLOS PATHOGENS (2010)
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
Michael Schotsaert et al.
EXPERT REVIEW OF VACCINES (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team
Fatimah S. Dawood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca J. Garten et al.
SCIENCE (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
Seasonal Influenza Vaccine Provides Priming For A/H1N1 Immunization
Giuseppe Del Giudice et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses
Isabella Alberini et al.
VACCINE (2009)
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
Graeme E. Price et al.
VACCINE (2009)
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
Rongfang Wang et al.
ANTIVIRAL RESEARCH (2008)
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Xiaocong Yu et al.
NATURE (2008)
Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
Sanae Sasaki et al.
PLOS ONE (2008)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby et al.
PLOS ONE (2008)
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses
Ming-Wei Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cross-protection by MF59™-adjuvanted influenza vaccine:: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
Filippo Ansaldi et al.
VACCINE (2008)
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin
James W. Huleatt et al.
VACCINE (2008)
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans
Matthew R. Sandbulte et al.
PLOS MEDICINE (2007)
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
G Del Giudice et al.
VACCINE (2006)
The structure and receptor binding properties of the 1918 influenza hemagglutinin
SJ Gamblin et al.
SCIENCE (2004)
Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis)
T Kuiken et al.
VETERINARY PATHOLOGY (2003)
分享论文
